Aspen to divest Asia Pacific operations in R26.5 billion value unlocking deal
IOL | 29.12.2025 12:28
Aspen Pharmacare has announced a major R26.5 billion transaction that will see its Asia Pacific business sold to Australian private investment firm BGH Capital as the group sharpens its strategic focus and reduces debt.
